New York, New York--(Newsfile Corp. - December 15, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Freeport-McMoRan Inc. (NYSE: FCX) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Freeport, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/freeport-mcmoran-inc-class-action-lawsuit.

New York, New York--(Newsfile Corp. - December 15, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Alexandria Real Estate, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/alexandria-real-estate-class-action-lawsuit.

Copart, Inc. receives a Buy rating, supported by a strong moat, capital-light model, and a rock-solid, debt-free balance sheet with $5.2 billion in cash. Despite recent revenue and unit volume declines, CPRT's network effects, strategic land ownership, and financial flexibility underpin long-term competitive advantages. Short-term risks include market share loss to RB Global, Inc. (RBA) and weak quarterly figures, but historical outperformance and attractive valuation offer compelling entry points.

NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Gauzy Ltd. (NASDAQ: GAUZ) between March 11, 2025 and November 13, 2025. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 6, 2026 .

Billings Clinic-Logan Health, Children's Hospital Los Angeles, and Regency Integrated Health Services move business applications to the cloud AUSTIN, Texas , Dec. 15, 2025 /PRNewswire/ -- Leading healthcare organizations are implementing Oracle Fusion Cloud Applications to help increase productivity, reduce costs, and enhance the experience they deliver to employees and patients. Billings Clinic-Logan Health, Children's Hospital Los Angeles, and Regency Integrated Health Services are leveraging Oracle Fusion Applications to streamline finance, HR, supply chain, and customer experience processes in the cloud.

Columbia Threadneedle Investments just released six new ETFs, including five which are actively managed and one tied to an index. All funds target specific segments in the equities as well as the fixed income market.

BOSTON, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced that its Chief Executive Officer, Ivor Elrifi, has purchased 163,400 shares of Tiziana common stock in the open market. This brings his current purchased shares total to 357,848.

BETA Technologies aims to revolutionize aerospace with electric aircraft, but faces significant near-term losses and delayed commercial certification. Despite a $3.5 billion backlog and 891 aircraft orders, only 289 are firm, and average plane prices appear high relative to current capabilities. BETA's Q3 revenue was $8.9 million with a $67 million negative EBITDA, and Q4 losses are expected to worsen, pressuring its $1.8 billion cash position.

SAN DIEGO--(BUSINESS WIRE)---- $TLX #Telix--Robbins LLP: Company: Telix Pharmaceuticals Ltd. (NASDAQ: TLX) is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. What is the class period? February 21, 2025 - August 28, 2025 What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or acquired Telix securities during the class peri.

Shares of Broadcom, CoreWeave and Oracle all dropped on Monday, extending last week's declines. While the artificial intelligence boom shows no signs of easing, investors have grown concerned about how it will all be financed.

DKS is scaling a multibillion-dollar e-commerce business as GameChanger and the Dick's Media Network power digital growth and omnichannel engagement.

SAN DIEGO--(BUSINESS WIRE)---- $FCX #Gas--Robbins LLP: Company: Freeport-McMoran Inc. (NYSE: FCX) is a mining company. What is the class period? February 15, 2022 - September 24, 2025 What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Freeport during the class period because the Company allegedly misled investors regarding safety at its mines. For more information, submit a form, email attorney Aaron Dumas, Jr.

Sanofi faces a setback as tolebrutinib fails its Phase 3 PPMS trial, halting regulatory pursuit for this indication. Meanwhile, an approval decision on the candidate has also been delayed. SNY's growth remains robust, with Q3 sales up 7% YoY, net income up 10%, and Dupixent driving ~35% of total revenues. Despite pipeline disappointments, SNY expects high single-digit sales and low-double-digit EPS growth for 2025, supported by new drug launches.

AC Immune receives a "Buy" rating, driven by positive phase 2 VacSYn trial results for ACI-7104.056 in early Parkinson's Disease. AC Immune is advancing ACI-7104.056, with upcoming FDA discussions to potentially establish a registration study as a key value-driving catalyst. The company benefits from a robust pipeline, including partnerships with Takeda and Johnson & Johnson, and significant milestone opportunities.

SAN DIEGO , Dec. 15, 2025 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether Ardent Health, Inc. (NYSE: ARDT) or certain of its officers and directors violated federal securities laws by making false or misleading statements and/or failing to disclose material information to investors. Background of the Investigation On November 12, 2025, Ardent issued a press release announcing its financial results for the third quarter of 2025.

SAN DIEGO , Dec. 15, 2025 /PRNewswire/ -- Johnson Fistel, PLLP is investigating potential derivative claims on behalf of Molina Healthcare, Inc. (NYSE: MOH) regarding alleged fiduciary breaches tied to undisclosed medical cost trends. The related class action covers February 5, 2025 through July 23, 2025.

F-16 platform strengthens national defense, deepens NATO and allied air integration GREENVILLE, S.C. , Dec. 15, 2025 /PRNewswire/ -- Lockheed Martin (NYSE: LMT) has completed production of all F‑16 Block 70 aircraft for Bulgaria and Slovakia's initial fleets, equipping both air forces with advanced F-16s ready for NATO and allied operations.

SAN DIEGO , Dec. 15, 2025 /PRNewswire/ -- Johnson Fistel, PLLP is investigating potential derivative claims on behalf of aTyr Pharma, Inc. (NASDAQ: ATYR) concerning alleged fiduciary breaches tied to disclosures around the Phase 3 EFZO-FIT clinical trial. The relevant class action covers November 7, 2024 through September 12, 2025.

Steven Sintros and Joseph Nowicki Re-Elected to Company's Board of Directors Steven Sintros and Joseph Nowicki Re-Elected to Company's Board of Directors

RADNOR, Pa., Dec. 15, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Firefly Aerospace Inc. (“Firefly”) (NASDAQ: FLY) on behalf of those who purchased or otherwise acquired Firefly: (1) common stock pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Offering Documents”) issued in connection with the company's IPO conducted on or about August 7, 2025; and/or (2) securities between August 7, 2025 and September 29, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is January 12, 2026.